Currently, percutaneous coronary intervention is an important treatment for coronary heart disease. However, the instent restenosis rate is still approximately 10-30% after stenting. Nickel ions from the stent are considered to be associated with in-stent restenosis. Therefore, in the present study, we quantitatively evaluated in-stent restenosis after implanting the novel high-nitrogen low-nickel coronary stent (HNS) and studied the mechanism underlying the reduction in in-stent restenosis by using ELISA and Western blot. The in vivo results showed that the HNS could significantly reduce neointima formation and inflammation as compared to SUS316L stents (316L) at 180 days after implantation in porcine coronary arteries and that vascular endothelial growth factor-A expression in porcine coronary arteries after HNS implantation also decreased. The in vitro results showed that, in the case of the HNS, human umbilical vein endothelial cell (HUVEC) proliferation was lower and lesser IL-6 release was noted from HUVECs at one and three days after culture than in the 316L group. Furthermore, p-STAT3 expression in HUVECs on the HNS surface was downregulated after culture for seven days. Thus, we conclude that the HNS could be a promising alternative coronary stent for percutaneous coronary intervention.
Introduction
Percutaneous coronary intervention (PCI) is an important treatment for coronary heart disease, and stents are the most important medical device for PCI. 1, 2 Currently, two types of coronary artery stents are available: bare metal stents (BMSs) and drug-eluting stents (DES). 3 Both of them are composed of metals with excellent mechanical properties such as strength and hardness compared to other materials used for stents. 4 There are three types of metallic materials such as cobalt-chromium (Co-Cr) alloy, stainless steel (SS), titanium alloy, and nitinol (NiTi) widely used as coronary artery stent. Among these materials, low carbon austenitic stainless steel (316L) is the most commonly used for stent because of its high ductility, high mechanical strength, good fatigue performance, good biocompatibility, and also excellent corrosion resistance. However, it is reported that BMSs have higher risks of restenosis after PCI because the stent may release nickel (Ni) ions which lead to allergic reactions resulting in fibroproliferative disorders around the stent. [5] [6] [7] It is reported that Ni ions can cause cytotoxicity, activate inflammatory processes, and increase the production of inflammatory cytokines, including interleukin (IL)-1b, IL-6, and tumor necrosis factor (TNF).
could induce the restenosis to relate with vascular endothelial growth factor (VEGF). It is reported that VEGF can accelerate re-endothelialization in the rat carotid artery and attenuate intimal hyperplasia. 11 Thus, VEGF and IL-6 are related to restenosis.
Although Ni allergy is associated with higher risks of restenosis after stenting, it is necessary to add Ni to the stent to increase its flexibility. 12 And before clinical application, the effect of 316L-Ni on endothelialization in vitro and in vivo should be seriously studied. Other group had evaluated the effect of high-nitrogen Ni free austenitic SS stent in porcine for 15 and 30 days. 13 Therefore, our group investigated a 180-day longterm observation including evaluations of the effect of a high-nitrogen low-Ni austenitic stainless steel (HNS) stent on endothelialization and the in vitro experiments included evaluations of the proliferation of human umbilical vein endothelial cells (HUVECs) and the inflammatory response of the stent to test the mechanism of the effect of Ni-reduced stainless on neointimal hyperplasia. This study hopes that the in vitro and in vivo tests could provide scientific data for the clinical promising application of a HNS stent.
Materials and methods

Stent
Two types of stents with the same structure and sizes (3.0 mm Â 12 mm) were analyzed. We used stents with the same diameter and radial force as a backbone and deployed them in the appropriate diameter of blood vessels for in vivo swine tests to minimize any other complex factors associated with the stent radial force. The low carbon austenitic stainless steel stent served as a control compared with HNS (purchased from Liaoning Biomedical Materials R&D Center Co. Ltd.) stents. The HNS stent contained C (0.12%), Si (0.79%), Mn (12.3%), P (0.008%), Cr (16.19%), Mo (3.24%), Ni (0.06%), and N (0.94%). The Ni content of 316L was 12%.
Surgery procedure
All the animal experiments were conducted according to the guidelines for the China Animal Care and Use of Laboratory and were approved by Institutional Animal Care and Use Committee of JILIN University. Six Yorkshire pigs (weight, 35 kg to 40 kg) were purchased from a Shanghai Huaxin special animal farm (SCXK (Shanghai), 2007-0013) and maintained on a regular chow diet. The pigs were fed in a suitable animal house with a constant temperature and humidity, and each one or two pigs were raised in a cage with appropriate size.
To prevent acute thrombosis after stenting, all pigs were orally administered aspirin (100 mg/d) and clopidogrel (75 mg) starting at one day before the procedure and throughout the study period. On the day of surgery, the pigs were subject to general anesthesia with halothane (0.3% to 0.6%) and received a total of 12 stents, including six of 316L and six of HNS stents. All stents were randomly assigned and placed in the left anterior descending (LAD), circumflex (LCX), or right coronary artery (RCA) (two types of stents per two arteries of one pig) via the femoral artery. Further details are provided in Table 1 . According to the target vessel diameter, the appropriate stent was delivered to the intended site via fluoroscopic guidance of digital subtraction angiography (DSA, GE Healthcare Bio-Sciences, Piscataway, NJ) and the stent size was selected (stent expanded diameter to artery diameter ¼ 1.1:1-1.2:1). After stent implanted and six months later, angiograms were performed to make sure that no serious dissection and thrombosis occurred ( Figure 1 ). After the stent placement, all pigs were maintained on their usual diet until further experiments begin.
Histopathological examination
Tissue harvest. At 180 days of stent implantation, the animals were killed by injection of sodium pentobarbital (60 mg/kg i.v.) and exsanguinated from ascending aorta. The hearts were removed and perfused with 0.9% saline until they were clear of blood, at a pressure of 100 mmHg (1 mmHg ¼ 0.0133 kPa). The stented arterial segments were dissected and sliced (50 lm) with a hard tissue microtome (LEICA, Germany). The sections were stained with hematoxylin-eosin (HE) and elastic fiber dyeing and used for light microscopy examination.
Measurement of the neointimal area. Lumen area (LA), area around internal elastic lamina area (area around IELA), neointimal area (NA ¼ area around internal elastic lamina À lumen area) and percent area stenosis (PAS ¼ NA/area around IEL Â 100%) were measured by a calibrated microscope, digital video imaging system, and microcomputer program (Visus, 2000 Visual Image Analysis System; IMT Tech, San Diego, CA). For each stented segment, five cross sections from the proximal and distal ends and three sections in the midpoints were measured.
Calculation of inflammation scores. Histopathologic evaluation was conducted by an experienced cardiovascular pathologist. The inflammation score for each strut was graded according to the inflammatory cells as reported by Cilingiroglu et al.: 14 0 ¼ no inflammatory cells surrounding the strut; 1 ¼ scattered inflammatory cells surrounding the strut; 2 ¼ inflammatory cells encompassing 50% of a strut in at least 25-50% of the circumference of the artery; 3 ¼ inflammatory cells surrounding a strut in at least 25-50% of the circumference of the artery.
Q-PCR. RNA extraction and purification
Vessels were dissected and frozen at À80 C. Samples were homogenized using TRIzol (Invitrogen) and separated into three phases-a lower red, phenolchloroform phase, an interphase, and a colorless upper aqueous phase-by chloroform as described by Zhao et al. 15 Quantitative real-time reverse-transcriptase polymerase chain-reaction (RT-qPCR) analyses
Prior to cDNA synthesis, RNA samples were treated with gDNA eraser (TAKARA Ambion) to remove genomic DNA contamination, and 400 ng of total RNA was converted into first strand cDNA with Oligo(dT) and random 6 mers (TAKARA Ambion). Quantitative fluorescence PCR was performed using the Mx3000p sequence detection system using the following program: denaturation at 94 C for 30 s and 40 cycles of denaturation at 94 C for 30 s and annealing and extension at 60 C for 20 s. The q-PCR data were analyzed by the DDCt method and b-actin cDNA was used as an internal control. The primer sequences of VEGF-A from Sangon Biotech (Shanghai, China) were as follows: forward, ACGAAGGT C T G GAGTGTGTG and reverse, CATTTGTTG TG CTGTAGGAAGC.
In vitro experiments
Proliferation of HUVECs on stents. HUVECs (purchased from KeyGEN Biotech, Nanjing, China) were cultured on 316L and HNS substrates in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Beijing Huamaike Biotechnology Company, China) and were maintained at 37 C in a humidified incubator with 5% CO 2 . The medium was replaced 2-3 times a week. After the HUVECs achieved confluence, they were trypsinized and resuspended in fresh media. HUVECs were labeled by a red cell membrane fluorescent probe (DiI) in ethanol solution. HUVEC suspensions with resulting density of 20,000 cells/ml were subsequently seeded on six-well plates (Thermo Fisher Scientific, USA), which contained one type of stent per plate. Then, the plates were incubated at 37 C in a humidified 5% CO 2 atmosphere. At one, three or five days after incubation, the viability of HUVECs on the surface of stents was recorded using fluorescence microcopy (Olympus IX81, Japan).
ELISA. The level of the inflammatory cytokine-6 (IL-6) was measured by a flow-based ELISA system (R&D SYSTEM, USA) after one and three days in the supernatant of HUVECs. The target protein was detected according to the manufacturer's instructions by using a commercial kit (R&D SYSTEM).
Western blot. The total proteins of HUVECs were extracted using ice-cold cell lysis buffer as described by Zong et al. 16 Then, the concentration of total proteins was detected by the bicinchoninic acid (BCA) method. The proteins were electrophoresed on 12% SDS-PAGE gels at 90 V for 3 h and then transferred onto polyvinylidene difluoride (PVDF) membranes at 200 mA for 1 h. The membrane was blocked with 3% fat-free milk in distilled water for 1 h at room temperature. Targeted proteins were detected using phosphosignal transducer and activator of transcription 3 (p-STAT3, 1:200; Biosynthesis Biotechnology Co., Ltd., Beijing, China), b-actin (1:2000, Biosynthesis Biotechnology Co., Ltd.). The secondary antibody conjugated with horseradish peroxidase (Biosynthesis Biotechnology Co., Ltd.) and enhanced chemiluminescence reagents (Biosharp) were incubated for 1 h at room temperature. Quantification of protein bands was performed using Image J. The levels in blots were normalized to the corresponding levels of b-actin. All the assays were independently repeated at least three times.
Results
Neointima formation after coronary stent implantation
Quantitative imaging results for neointima formation at 180 days after stenting are provided in Table 2 and Figure 2 . The stenosis area in the HNS group was significantly lower than that in the 316L group (p < 0.05). The neointimal thickness in the HNS group was also lower than that in the 316L group; however, the difference was not statistically significant.
Inflammation scores for the HNS and 316L groups
At 180 days, the HNS group had lower inflammatory scores than the 316L group (Figure 3) . The inflammatory score in 316L group is 2.67 AE 0.57 larger than that in HNS group (1.67 AE 0.57, unpaired t-test, p > 0.05). 
VEGF-A expression in porcine coronary arteries after HNS and 316L stent implantation
mRNA expression levels of VEGF-A weakly increased on implantation of 316L stents (2.443 AE 0.616) as compared to the levels seen with HNS stents (1.22 AE 0.114, Figure 4 ); these differences were not significant (p > 0.05, one-way ANOVA, n ¼ 3 arteries per group). But mRNA expression levels of VEGF-A in control group (0.789 AE 0.158) was lower than that in 316L group (2.443 AE 0.616, p < 0.05, one-way ANOVA, n ¼ 3 arteries per group).
Cell proliferation of HUVECs on the 316L and HNS stents
HUVECs were seeded on the steel substrates on the sixwell plates and then incubated at 37 C for one, three or five days. Furthermore, HUVECs on the stent were also labeled by DiI which can stain only the living cells and their images were recorded under a fluorescence microscope. Figure 5 (a-f) shows that the numbers of the living HUVECs on different steel substrates. The cell number of 316L group was higher than that of HNS group. The average amount of the HUVECs adhered on the 316L stent was greater than that on the HNS stent after culture for five days ( Figure 5(g) ).
IL-6 release by HUVECs after culture
IL-6 levels were analyzed after one and three days in the culture medium. The HNS group (0.23 AE 0.008) showed lesser IL-6 release than the 316L group (0.309 AE 0.022) after one day culture (p < 0.01, Figure 6 ). The result after three days culture also showed lower IL-6 release in HNS group (0.2633 AE 0.008) than in 316L group (0.35 AE 0.035, p < 0.05, Figure 6 ).
p-STAT3 expression in HUVEC s on the surface of the stents after culture
Western blot results showed that HUVECs grown on the surface of HNS stents (0.2101 AE 0.005）showed lower p-STAT3 expression than those on the 316L stent (0.2485 AE 0.006, p < 0.05) after seven days of culture ( Figure 7 ).
Discussion
Our current results showed that, as compared to the SUS316L stents, the HNS stent could significantly reduce neointima formation and inflammation after implantation in porcine coronary arteries; VEGF-A expression in porcine coronary arteries after HNS stent implantation also decreased. We also found that HUVEC proliferation on the surface of the HNS stent and IL-6 release from HUVECs in medium after culture in the case of the HNS stent were also lower than those for the 316L group. Moreover, p-STAT3 expression in HUVECs on the surfaces of the HNS stent also decreased.
In-stent restenosis is an important clinical phenomenon after stenting. When BMS is widely implanted, it was found that one of the reasons for in-stent restenosis is the Ni in the metal stent, which is reported to be associated with higher risks of restenosis after stenting.
6,9 DES can reduce intimal hyperplasia in stented segments compared with BMS. 17 But it is reported that DES after implantation can strongly suppress acutephase inflammation and also promote late-stage inflammation. 18 These may cause late lumen loss and may be one of the reasons for the late catch-up phenomenon. First generation DES was mostly the 316L stent containing approximately 14% Ni. 19 It is considered that Ni in first generation DES was also one of the reasons related with late catch-up phenomenon. Therefore, second generation DES with lower Ni or Ni free metal has lower in-stent restenosis rate compared with first-generation DES. In the past two decades, the HNS stent, which uses one of the many novel biomaterials developed for stents, has been developed to avoid stent restenosis. In our study, it was found Figure 6 . Effects of HNS and 316L stents on IL-6 release from HUVECs in the medium at one and three days after culture, measured using ELISA. HNS: high-nitrogen low-nickel coronary stent.
that the HNS stent decreased the neointima formation in porcine coronary arteries at 180 days after implantation and also decreased HUVEC proliferation. However, previous studies showed neointima formation in porcine coronary arteries in HNS implantation had no difference with that in 316 group at 15 or 30 days after implantation. 13 The reason why there was no difference in neointima formation between 316L and HNS group at early stage may be that the release of Ni ion in metal is a slow process. Therefore, our result indicated that the long-term effect of HNS stent in neointima formation was better than that of 316L stent. Furthermore, an in vitro study found that HUVECs in the 316L group have high proliferation rate compared with HNS group. 20 Our results were the same with that research.
To study the mechanism underlying HNS stent reduction of neointima formation, we calculated the inflammatory scores and analyzed VEGF mRNA expression in porcine coronary arteries at 180 days after implantation and IL-6 release from HUVECs in the medium on culture with the two types of stents. The results showed that the inflammatory scores, VEGF mRNA expression, and IL-6 release in the HNS group were lower than those in the 316L group. Although VEGF mRNA expression was decreased in HNS group, the decrease showed no significance in statistics. It is because that the sample was only three in one group. The sample we collected from the surface of the stent is only a little. It is widely known that VEGF is involved in promoting neovascularization. 21 Our results also indicated that the high rate of neointima formation in 316L group had the relationship with high expression of VEGF.
In a previous study, it was found that IL-6 and VEGF levels in the peripheral blood of patients increased at four weeks after PCI, which may indicate that the risk of angiographic restenosis increased. Both Katsaros et al. 22 and Kazmierczak et al. 23 found that the increase in the plasma levels of VEGF at 24 h after PCI is associated with an increased risk of in-stent restenosis. The plasma concentration of IL-6 may be a marker of in-stent restenosis in patients after PCI. Our results suggested that the HNS stent may inhibit the secretion of pro-inflammatory mediators to decrease the risk of restenosis.
STAT3 is a member of the Janus-activated kinase (Jak)/Stat signaling pathway. Activation of the STAT3 signaling pathway by IL-6 can increase the expression of the VEGF-encoding genes. 24 The IL-6Ra-IL-6 complex increases VEGF expression with activation of STAT3 and ERK and inhibits VEGF expression in mice by selective blockade of IL-6 trans-signaling. 25 Our in vitro results agree with those of other studies in that the expression of p-STAT3 in HUVECs on the surface of the HNS stent decreased, which may be because IL-6 level in the HNS was lower than that in 316L stent.
Conclusion
In this study, we found that arteries implanted with the HNS stents showed less neointima formation and inflammation than those implanted with 316L stents after 180 days of implantation. Furthermore, our in vitro results showed that the number of cells cultured on HNS stent was lower than that on 316L. It might be attributed to those HUVECs on HNS stent surface released less IL-6 and expressed lower STAT3. Thus, the HNS stent is a promising alternative coronary stent for PCI.
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